CHIRON CONSULTATION & THERAPY SERVICES LIMITEDActive

Company number 03445907Private limited companyIncorporated 1997

Key figures

£75,277+6.4%
Net assets 2024/25
+24.9%
Average annual growth 2019/20–2024/25
020 k40 k60 k80 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, CHIRON CONSULTATION & THERAPY SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand53,71060,83569,90063,54555,371
Total assets58,51066,56679,46388,42579,207
Total liabilities——19,95817,6543,930
Net assets / total equity41,14652,05559,50570,77175,277
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CHIRON CONSULTATION & THERAPY SERVICES LIMITED

Company

CHIRON CONSULTATION & THERAPY SERVICES LIMITED is a private limited company registered with Companies House under company number 03445907. It was incorporated on 7 Oct 1997. Its status is active. The registered office is in Woolwich (SE18). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files abridged accounts (unaudited). Net assets were £75,277, up 6.4% on the previous year. Cash at bank and in hand was £55,371. Total assets were £79,207 and total liabilities £3,930. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 11 Jul 2027.